Richter Gedeon stock at EUR 33.88, up 27.0 percent year to date

Published on 10/12/2026 at 13:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

H1 revenue reached HUF 151.8 billion, up 3.00 percent year over year. Richter Gedeon stock has USD 6.8 billion market value on October 9, 2026.

Key points in brief

Richter Gedeon stock stood at EUR 33.88 at Lang & Schwarz on October 12, 2026 at 1:08 p.m. CEST.
The stock was up 27.01 percent year to date as of October 9, 2026.
First-half 2026 revenue reached HUF 151.8 billion, a 3.00 percent year-over-year increase.
The next reported earnings date is November 10, 2026, according to Yahoo Finance.

Richter Gedeon, HU0000123096, Illustration mit AI erstellt.

Richter Gedeon (ISIN HU0000123096) stood at EUR 33.88 at Lang & Schwarz on October 12, 2026 at 1:08 p.m. CEST. The stock was up 27.01 percent year to date as of October 9, 2026, while its latest reported first-half revenue reached HUF 151.8 billion, an increase of 3.00 percent from the year-earlier period.

Price and year-to-date position

The EUR 33.88 quote gives the stock a clear market reference for German investors during the trading session. Yahoo Finance reported a USD 6.8 billion market capitalization and a trailing P/E ratio of 9.87 for the October 9, 2026 quotation.

The year-to-date gain of 27.01 percent contrasts with a one-month decline of 8.69 percent in the same quotation series. That spread points to a stock that has retained a substantial annual advance while giving back part of its recent move.

Half-year figures and guidance

According to the Yahoo Finance transcript of the August 7, 2026 earnings call, constant-currency revenue growth reached 8.70 percent in the first half of 2026. Constant-currency Clean EBIT rose 21.00 percent in the same period, while reported revenue was HUF 151.8 billion.

The company also raised its 2026 pharma Clean EBIT outlook to double-digit constant-currency growth, according to the same earnings-call transcript. Management said the upgrade reflected VRAYLAR performance, stronger profitability and progress in biotechnology.

Comparison with peers

Richter Gedeon: P/E 9.87, market capitalization USD 6.8 billion

Bayer (Xetra, EUR): plus 0.23 percent, P/E minus 24.95, market capitalization EUR 43.1 billion

Hims & Hers Health (NYSE, USD): plus 10.19 percent, market capitalization USD 7.2 billion

Next reporting date

Yahoo Finance lists November 10, 2026 as the next earnings date for Gedeon Richter. The date gives the market a defined calendar point for the next update on revenue, profitability and the full-year outlook.

Richter Gedeon operates in specialty and generic pharmaceuticals, with activities spanning women's healthcare, central nervous system treatments, biotechnology and general medicines. The first-half figures place profitability and constant-currency growth alongside the share price as the key measures for the next report.

The further course of trading is shown by the continuously updated real-time quote of Richter Gedeon stock.